Hu Zhang

Professor of Bioprocessing

Keck Graduate Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hu Zhang is a Professor of Bioprocessing at Keck Graduate Institute, located in the United States. His research focuses on innovative nanomedicine applications for cancer therapy, including enzyme-triggered drug delivery systems and tumor-targeted nanovaccines. Additionally, he explores bioreactor technologies for cell therapy and the integration of imaging modalities for enhanced diagnostic and therapeutic outcomes.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hu Zhang

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine enables an enhanced cancer combination therapy

A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody

Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging

Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation

GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine

Bioreactor Technology for Cell Therapy Manufacturing in Regenerative Medicine

Fibre-Optic Surface Plasmon Resonance Biosensor for Monoclonal Antibody Titer Quantification

Enhanced chemo-photodynamic therapy of an enzyme-responsive prodrug in bladder cancer patient-derived xenograft models

Polysaccharide-based nanomedicines for cancer immunotherapy: A review

Correction to “NIPAM-Based Microgel Microenvironment Regulates Cardiac Stem Cells”

Make your next move.